0001441844-11-000025.txt : 20110622
0001441844-11-000025.hdr.sgml : 20110622
20110622165435
ACCESSION NUMBER: 0001441844-11-000025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110621
FILED AS OF DATE: 20110622
DATE AS OF CHANGE: 20110622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ISRAEL ROBERT J
CENTRAL INDEX KEY: 0001250274
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23143
FILM NUMBER: 11926024
MAIL ADDRESS:
STREET 1: 50 OXFORD DR
CITY: MONTEBELLE
STATE: NY
ZIP: 10901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000835887
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133379479
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9147892800
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0303
4
2011-06-21
0
0000835887
PROGENICS PHARMACEUTICALS INC
PGNX
0001250274
ISRAEL ROBERT J
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
Senior VP Medical Affairs
Common Stock
2011-06-21
4
S
0
7889
7.015
D
36151
D
Sale under a 10b5-1 Plan, which was established in accordance with the policies and procedures of the Issuer.
This transaction was executed in multiple trades at prices ranging from $7.00 to $7.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
By: Robert A. McKinney For: Robert J. Israel
2011-06-22